Enhancing the expression of interleukin-1 receptor-like 1 (ST2) is likely the key downstream mechanism underlying hematoma clearance enhanced by IL-4/STAT6 following ICH (Figure 2D). This evidence concerns the gene IL1RL1 and hematoma.